BANILA CO Prime Primer Sun (F&CO Co., Ltd.)


Welcome to the PulseAid listing for the BANILA CO Prime Primer Sun drug offered from F&CO Co., Ltd.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: F&CO Co., Ltd.
NON-PROPRIETARY NAME: Avobenzone, Octinoxate, Octocrylene, Octisalate, Homosalate, Ensulizole
SUBSTANCE NAME: AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OCTISALATE; HOMOSALATE; ENSULIZOLE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2017-10-01
END MARKETING DATE: 0000-00-00


BANILA CO Prime Primer Sun HUMAN OTC DRUG Details:

Item DescriptionBANILA CO Prime Primer Sun from F&CO Co., Ltd.
LABELER NAME: F&CO Co., Ltd.
DEA SCHEDULE:
ACTIVE STRENGTH: 1.05; 2.07; .6; 1.35; .9; 1.05(g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; g/30mL)
START MARKETING DATE: 2017-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69106-430_ef3cafa2-5e11-402f-9b58-0bb80e2cf672
PRODUCT NDC: 69106-430
APPLICATION NUMBER: part352

Other AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OCTISALATE; HOMOSALATE; ENSULIZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
F&CO Co., Ltd.BANILA CO Prime Primer Sun